New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2013
16:00 EDTOPKOPKO citicoline products approved for commercialization in Spain
OPKO Health announced that its Barcelona, Spain subsidiary, Pharmadiet, S.L.U., received regulatory approval from Spainís health authority for commercialization of its oral and injectable formulations of citicoline. Final marketing authorization is expected within 60 to 90 days.
News For OPK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 10, 2014
08:39 EDTOPKOPKO Health reports publication of validation of 4Kscore test in prostate cancer
OPKO Health announced the online publication of a multi-institutional, prospective study of the 4Kscore Test in the journal European Urology. The results of the study demonstrated that the 4Kscore provides a patient with accurate and personalized information about their risk of having Gleason Score °›7 prostate cancer, making it a useful tool for selecting men who have significant disease and are most likely to benefit from a prostate biopsy, the company said.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use